NORMOSTOP CAFEINA

This brand name is authorized in Spain

Active ingredients

The drug NORMOSTOP CAFEINA contains a combination of these active pharmaceutical ingredients (APIs):

1 Dimenhydrinate
UNII JB937PER5C - DIMENHYDRINATE

Dimenhydrinate is a theoclate salt of the ethanolamine derivative diphenhydramine. It exhibits reversible competitive antagonism with histamine for the capture of H1 receptors. It has anticholinergic (antimuscarinic) properties that explain the anti-emetic action of the drug in cases of labyrinthial irritation (nausea, vertigo), and the central suppression it causes.

Read about Dimenhydrinate
2 Caffeine
UNII 3G6A5W338E - CAFFEINE

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.

Read about Caffeine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R06AA Aminoalkyl ethers R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use
Discover more medicines within R06AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 83545

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.